Bay Street News

Crown Electrokinetics Reports Second Quarter 2024 Financial Results

LOS ANGELES, Aug. 14, 2024 (GLOBE NEWSWIRE) — Crown Electrokinetics Corp. (NASDAQ: CRKN) (“Crown” or the “Company”), a leading smart glass technology company and an expert in constructing fiber optic networks and lead pipe inspection and remediation, will report its financial results for the second quarter 2024 today, August 14, 2024.

Doug Croxall, Crown CEO and Chairman, “Our second quarter represents our best revenue quarter in our history. As of today, we have eliminated all investment debt and all classes of our preferred equity; thereby cleaning up both our balance sheet and cap table significantly. We have added to our senior management team and announced two new lines of business with lead pipe inspection and remediation. We are positioned for an outstanding second half of 2024, building atop of recent operational momentum that we expect will position Crown for a significant year of value creation in 2025.”    

Corporate Updates During and Subsequent to the Q2 2024

Financial Results for the Second Quarter ended June 30, 2024

Revenue:

For the quarter ended June 30, 2024, Crown booked $4.6 million of revenues compared to $0.7 million in the first quarter of 2024. For the six months ended June 30, 2024, the Company’s revenue was $5.3 million, compared to $0.1 million for the six months ended June 30, 2023.

Cost of revenue:

Cost of revenue was $4.0 million and $23,000 for the three months ended June 30, 2024, and 2023 and $5.8 million and $0.1 million for the six months ended June 30, 2024 and 2023, respectively.

Expenses:

Depreciation and amortization expense for the three months ended June 30, 2024 and 2023, were $0.2 million and $0.1 million, respectively.

Research and development expenses were $1.1 million for the three months ended June 30, 2024 compared to $0.5 million for the three months ended June 20, 2023.

General and administrative (“G&A”) expenses were $4.2 million for the quarter which included $2.4 of non-cash equity compensation expense. This represents a $0.1 million decrease in G&A expenses compared to 2023.

Loss from Operations:

Loss from Operations for the second quarter were $4.9 million, in line with the same quarter in 2023. June YTD operating losses were $8.6 million compared to $9.0 million in 2023.

Net losses:

Net losses were $5.0 million compared to $14.5 million in Q1 2023. June YTD Net losses were $9.6 million compared to $16.8 million in 2023.

Cash:

For the six months ended June 30, net cash increased $2.9 million to $4.0 million as the company deployed $8.9 million of cash for operations, $0.1 million for investments, and raised $11.8 million in financing activities.

Revenue guidance:

The Company expects third quarter revenues to be in line with previous guidance of $8.0 million.

Conference Call Information

To participate in this event, please log-on or dial-in approximately 5 to 10 minutes before the beginning of the call.

Date: August 14, 2024
Time: 12:00 PM ET
1-877-451-6152 or 1-201-389-0879
Conference ID: 13747919

Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1680379&tp_key=cade0c707f

Callme™: https://callme.viavid.com/viavid/?callme=true&passcode=13722237&h=true&info=company&r=true&B=6

Participants can use Guest dial-in #s above and be answered by an operator OR click the Call me™ link for instant telephone access to the event.
Call me™ link will be made active 15 minutes prior to scheduled start time.

Conference Call Replay Information

1-844-512-2921 or 1-412-317-6671

Access ID13747919

About Crown Electrokinetics

Crown is comprised of two divisions, Fiber Optics and Electrokinetics Film. The Electrokinetics Film division is a smart glass technology and the creator of our Smart Window Insert based on its patented electrokinetic film. Crown’s Fiber Optics division is a builder of underground fiber optic networks as well as other utility infrastructure projects.

Safe Harbor Statement: 

Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Crown Electrokinetic Corporation undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

Crown Electrokinetics

IR Email: info@crownek.com

Source: Crown Electrokineticswww.crownek.com

 
Crown Electrokinetics, Corp
Statements of Operations
(in thousands)                
    Three Months Ended June 30,   Six months ended June 30,
      2024       2023       2024       2023  
                 
Revenue   $ 4,648     $ 37     $ 5,330     $ 59  
                 
Cost of revenue, excluding depreciation and amortization     4,183       23       5,819       54  
Depreciation and amortization     74       81       286       263  
Research and development     1,111       490       1,867       1,031  
General and administrative     4,187       4,328       5,970       7,722  
Loss from operations     (4,907)       (4,885)       (8,612)       (9,011)  
                 
Other income (expense):                
Interest expense     (145)       (2,508)       (1,005)       (4,525)  
Loss on extinguishment of warrant liability                       (504)  
Loss on extinguishment of debt           (2,345)             (2,345)  
Gain on issuance of convertible notes                       64  
Change in fair value of warrants     23       2,130             7,736  
Change in fair value of notes           (6,883)             (7,000)  
Change in fair value of derivative liability                        
Other expense           (28)       (24)       (1,234)  
Total other income (expense)     (122)       (9,634)       (1,029)       (7,808)  
                 
Net loss     (5,029)       (14,519)       (9,641)       (16,819)  
Deemed dividend on Series D preferred stock                       (6)  
Cumulative dividends on Series A preferred stock           (5)             (9)  
Cumulative dividends on Series B preferred stock           (29)             (49)  
Cumulative dividends on Series C preferred stock           (10)             (10)  
Cumulative dividends on Series D preferred stock           (53)             (84)  
Cumulative dividends on Series D preferred stock                    
Cumulative dividends on Series D preferred stock                    
Cumulative dividends on Series D preferred stock                    
Cumulative dividends on Series D preferred stock                    
Cumulative dividends on Series F preferred stock                        
Cumulative dividends on Series F-1 preferred stock                        
Cumulative dividends on Series F-2 preferred stock                        
Deemed dividend in connection with conversion of Series A, Series B, and Series C preferred stock     (1,350)             (1,350)        
Deemed dividend in connection with conversion of Series F, F-1, and F-2     (3,874)             (3,874)        
Net loss attributable to common stockholders   $ (10,253)     $ (14,616)     $ (14,865)     $ (16,977)  
                 
Net loss per share attributable to common stockholders   $ (5.89)     $ (2,720.27)     $ (14.98)     $ (3,951.82)  
                 
Weighted average shares outstanding, basic and diluted:     1,739,995       5,373       992,278       4,296  
                 
 
 
Crown Electrokinetics, Corp          
Balance Sheets          
(in thousands)          
           
    June 30, 2024   December 31, 2023  
           
Cash   $ 3,990   $ 1,059  
Prepaid and other current assets     378     728  
Accounts receivable , net     3,351     83  
Other receivables     211      
Contract asset     1,244      
Total current assets     9,174     1,870  
Prepaid expenses long term     215      
Property and equipment, net     3,012     3,129  
Intangible assets, net     1,269     1,382  
Right of use asset     1,878     1,701  
Deferred debt issuance costs     292     1,306  
Other assets     160     139  
TOTAL ASSETS   $ 16,000   $ 9,527  
           
Accounts payable   $ 2,215   $ 1,500  
Accrued expenses     898     1,194  
Lease liability – current portion     735     655  
Notes payable short term     636     429  
Deferred revenue     1,260      
Total current liabilities     5,744     3,778  
Notes payable long term     296      
Lease liability – non-current portion     1,178     1,072  
Total liabilities     7,218     4,850  
           
Total stockholders’ equity     8,782     4,677  
TOTAL LIABILITIES AND EQUITY   $ 16,000   $ 9,527  
               
             
 
Crown Electrokinetics, Corp      
Statement of Cash flow      
(in thousands)      
    Six Months Ended June 30,
      2024       2023  
  CASH FLOWS FROM OPERATING ACTIVITIES      
  Net loss $ (9,641)     $ (16,819)  
  Adjustments to reconcile net loss to net cash used in operating activities:      
  Stock-based compensation   2,424       313  
  Depreciation and amortization   286       372  
  Loss on extinguishment of warrant liability         504  
  Change in fair value of warrant liability         (7,736)  
  Loss on extinguishment of debt         2,345  
  Change in fair value of notes         7,000  
  Amortization of deferred debt issuance costs   1,014       4,049  
  Amortization of right of use assets   383       1,045  
  Amortization of notes payable   (15)        
  Other expenses         1,275  
  Loss on disposal of equipment         235  
  Changes in operating assets and liabilities:        
  Prepaid and other assets   114       (14)  
  Accounts receivable   (3,268)        
  Contract asset   (1,244)      
  Note receivables   (211)        
  Contract liabilities   1,260        
  Accounts payable   715       886  
  Accrued expenses   (296)       (742)  
  Lease liability   (374)       (1,101)  
  Warranty customer liability          
  Net cash used in operating activities   (8,853)       (8,388)  
  CASH FLOWS FROM INVESTING ACTIVITIES      
  Cash paid for acquisition of Amerigen 7         (644)  
  Purchase of equipment   (56)       (707)  
  Net cash used in investing activities   (56)       (1,351)  
  CASH FLOWS FROM FINANCING ACTIVITIES      
  Proceeds from the exercise of warrants         2,061  
  Proceeds from the issuance of common stock / At-the-market offering   588       2,198  
  Proceeds from the issuance of notes in connection with Line of Credit         2,350  
  Offering costs for the issuance of common stock / At-the-market offering         (91)  
  Proceeds from issuance of Series F-1 preferred stock         2,328  
  Proceeds from issuance of Series F-2 preferred stock         748  
  Proceeds from issuance of January promissory notes, net of fees paid         1,357  
  Borrowing of notes payable   1,164        
  Repayment of notes payable   (646)       (1,997)  
  Proceeds from the issuance of common stock in connection with equity line of credit, net of offering costs   10,734        
  Net cash provided by financing activities   11,840       8,954  
         
  Net increase / decrease in cash   2,931       (785)  
  Cash — beginning of period   1,059       821  
  Cash — end of period $ 3,990     $ 36  
         


Bay Street News